A major international collaboration led by Melbourne researchers has discovered that the world’s most widespread malaria parasite infects humans by hijacking a protein the body cannot live without.
The researchers were then able to successfully develop antibodies that disabled the parasite from carrying out this activity.
The study, led by the Walter and Eliza Hall Institute’s Associate Professor Wai-Hong Tham and Dr Jakub Gruszczyk, found that the deadly malaria parasite Plasmodium vivax (P. vivax) causes infection through latching onto the human transferrin receptor protein, which is crucial for iron delivery into the body’s young red blood cells.
Published today in Science, the discovery has solved a mystery that researchers have been grappling with for decades.
Associate Professor Tham, who is also a HHMI-Wellcome International Research Scholar, said the collective efforts of teams from Australia, New Zealand, Singapore, Thailand, United Kingdom, United States, Brazil and Germany had brought the world closer to a potential effective vaccine against P.vivax malaria.
“P. vivax currently inflicts a huge burden on global health. It is the most common malaria parasite in countries outside of Africa, with more than 16 million clinical cases recorded each year.
“The parasite can lie dormant in the liver for months on end without causing any symptoms, which makes it very sneaky and difficult to treat,” Associate Professor Tham said.
“We now know that P. vivax is hijacking the human transferrin receptor which is essential for transporting iron into the body’s young red blood cells.
“Being able to stop P. vivax from latching onto this receptor and infliltrating the blood is a major breakthrough and important step towards malaria elimination,” she said.
Dr Gruszczyk said once the teams understood how the parasite was gaining entry into the cells, they were able to design antibodies to block the mode of access.
“Using the Australian Synchrotron in Melbourne, we generated a 3D map of the parasite protein which is the mechanism P. vivax uses to latch onto the human transferrin receptor and enter the young red blood cells.
“This map provided an unprecedented view of the parasite protein’s shape, which guided the design of antibodies to block P. vivax from gaining entry into the human cells,” Dr Gruszczyk said.
Associate Professor Tham said they were thrilled to see the antibodies successfully block P. vivax invasion using parasites from both Thailand and Brazil. “We are now looking to include collaborative partners in the Pacific, so we can further test the effectiveness of our antibodies,” she said.
Study collaborator Dr Jonathan Abraham from Harvard University said the results of the new study aligned with a growing body of evidence that could be used to target multiple infectious diseases.
“Transferrin receptor is also co-opted by five viruses that cause Ebola-like diseases in South America. These diseases are known as New World haemorrhagic fevers.
“Our increasing understanding of how several pathogens are taking advantage of transferrin receptor, means we are getting closer to disrupting infection for a number of deadly diseases,” Dr Abraham said.
Learn more: Hijacker parasite blocked from infiltrating blood
The Latest on: Malaria parasite
[google_news title=”” keyword=”malaria parasite” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Indonesia faces uphill battle to eliminate malaria in eastern regionson May 1, 2024 at 12:47 am
As the government continues to mark successes in its effort to eliminate malaria in all 514 cities and regencies nationwide, the country's eastern regions pose distinctive challenges due to their ...
- New monoclonal antibody vaccine slashes malaria risk in childrenon April 30, 2024 at 8:19 pm
A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and significantly reduces the risk of malaria infection and clinical symptoms by 70% and ...
- Sarasota County prepares for mosquito season after last year’s malaria outbreakon April 30, 2024 at 3:29 pm
As we inch closer to some of the rainiest months of the year, residents can expect to see more mosquitoes out and about.
- Malaria: The plight of residents of low-income neighbourhoodson April 30, 2024 at 2:25 am
Ponds of dirty water on the streets of Makoko, an informal neighborhood in Lagos, and a lack of decent living conditions provide ideal breeding conditions for malaria-spreading mosquitoes. Globally, ...
- Making transfusion-transmitted malaria in Europe a thing of the paston April 26, 2024 at 3:10 pm
The current strategy used in Europe to mitigate malaria transfusion risk is efficient with just 10 reported cases over the 20 past years. However, current serological tests used to identify "at risk" ...
- Q&A: Scientist who helped design R21 anti-malaria vaccine reflects on 30 years of research, and what it promiseson April 25, 2024 at 9:17 am
Until three years ago nobody had developed a vaccine against any parasitic disease. Now there are two against malaria: the RTS,S and the R21 vaccines.
- Vaccines are a glimmer of hope against malaria, but the battle has only just begunon April 25, 2024 at 6:10 am
By the time you reach the end of this article, three children will have died from malaria – a disease that casts a dark shadow over nearly half of the world’s population, claiming victims ...
- Why the fight against malaria is having a ‘Red Queen’ momenton April 25, 2024 at 4:41 am
For malaria researchers and practitioners, this sensation feels all too familiar. Despite several exciting advances, efforts to tackle the parasitic pathogen have stalled since 2015: then, according ...
- Malaria parasites can evade rapid tests, threatening eradication goalson April 24, 2024 at 5:00 pm
But this progress could be undermined by the malaria-causing parasite itself. Mutations that render Plasmodium falciparum invisible to the current gold-standard rapid test are spreading across ...
- Can climate change accelerate transmission of malaria? New research sheds light on impacts of temperatureon April 24, 2024 at 10:41 am
Malaria is a mosquito-borne disease caused by a parasite that spreads from bites of infected female Anopheles mosquitoes. If left untreated in humans, malaria can cause severe symptoms, health ...
via Google News and Bing News